Comparison of 1-Year Outcomes of Triple (Aspirin+Clopidogrel+Cilostazol) Versus Dual Antiplatelet Therapy (Aspirin+Clopidogrel+Placebo) After Implantation of Second-Generation Drug-Eluting Stents into One or More Coronary Arteries: …
Comparison of a Simple Angiographic Approach With a Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Score-Based Approach for Left Main Coronary Artery Stenting: ...
Coronary CT angiography characteristics of OCT-defined thin-cap fibroatheroma: a section-to-section comparison study.
Incremental Value of Subtended Myocardial Mass for Identifying FFR-Verified Ischemia Using Quantitative CT Angiography: Comparison With Quantitative Coronary Angiography and CT-FFR.
Benefit of Final Kissing Balloon Inflation Mandatory After Simple Crossover Stenting for Left Main Bifurcation Narrowing.
Comparative determinants of 5-year cardiovascular event rates in patients with unprotected left main coronary artery disease.
Comparative effectiveness of coronary screening in heart valve surgery: Computed tomography versus conventional coronary angiography.
Comparison of Outcome of Coronary Artery Bypass Grafting Versus Drug-Eluting Stent Implantation for Non-ST-Elevation Acute Coronary Syndrome.
Comparison of Outcomes of Coronary Artery Bypass Grafting Versus Drug-Eluting Stent Implantation in Patients With Severe Left Ventricular Dysfunction.
Comparison of Stenting Versus Bypass Surgery According to the Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of the SYNTAX, PRECOMBAT, and BEST Trials.
Comparison of long-term mortality according to obesity in patients with successful percutaneous chronic total occlusion interventions using drug-eluting stents.
Coronary Artery Bypass Grafting vs. Drug-Eluting Stent Implantation for Multivessel Disease in Patients with Chronic Kidney Disease.
Coronary artery bypass graft surgery versus drug-eluting stent implantation for high-surgical-risk patients with left main or multivessel coronary artery disease.
Diagnostic performance of on-site CT-derived fractional flow reserve versus CT perfusion.
Differential Event Rates and Independent Predictors of Long-Term Major Cardiovascular Events and Death in 5795 Patients With Unprotected Left Main Coronary Artery Disease Treated With Stents, Bypass Surgery, or Medication: …
Differential Rates and Clinical Significance of Periprocedural Myocardial Infarction After Stenting or Bypass Surgery for Multivessel Coronary Disease According to Various Definitions.
Early experience and favorable clinical outcomes of everolimus-eluting bioresorbable scaffolds for coronary artery disease in Korea.
Everolimus- versus zotarolimus-eluting stent following percutaneous coronary chronic total occlusion intervention.
Fractional Flow Reserve and Cardiac Events in Coronary Artery Disease: Data From a Prospective IRIS-FFR Registry (Interventional Cardiology Research Incooperation Society Fractional Flow Reserve).
Fractional flow reserve and pressure-bounded coronary flow reserve to predict outcomes in coronary artery disease.
Full Metal Jacket With Drug-Eluting Stents for Coronary Chronic Total Occlusion.
Generalizability of EXCEL and NOBLE results to a large registry population with unprotected left main coronary artery disease.
Geographical Difference of the Interaction of Sex With Treatment Strategy in Patients With Multivessel Disease and Left Main Disease: A Meta-Analysis From SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery), PRECOMBAT (Bypass Surgery Versus A
Impact of Follow-Up Ischemia on Myocardial Perfusion Single-Photon Emission Computed Tomography in Patients with Coronary Artery Disease.
Impact of Multivessel Coronary Artery Disease With Versus Without Left Main Coronary Artery Disease on Long-Term Mortality After Coronary Bypass Grafting Versus Drug-Eluting Stent Implantation.
Impact of coronary lumen reconstruction on the estimation of endothelial shear stress: in vivo comparison of three-dimensional quantitative coronary angiography and three-dimensional fusion combining optical coherent tomography.
Impact of design of coronary stents and length of dual antiplatelet therapies on ischaemic and bleeding events: a network meta-analysis of 64 randomized controlled trials and 102 735 patients.
Impact of left main coronary artery disease on long-term mortality in patients undergoing drug-eluting stent implantation.
Impact of the SYNTAX scores I and II in patients with diabetes and multivessel coronary disease: a pooled analysis of patient level data from the SYNTAX, PRECOMBAT, and BEST trials.
Long-term outcomes of bypass grafting versus drug-eluting stenting for left main coronary artery disease: Results from the IRIS-MAIN registry.
Mortality of patients with previous stroke undergoing drug-eluting stent implantation.
Outcomes of Coronary Artery Bypass Graft Surgery Versus Drug-Eluting Stents in Older Adults.
Predictors of long-term outcomes after bypass grafting versus drug-eluting stent implantation for left main or multivessel coronary artery disease.
Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents.
Relationship Between Serum Inflammatory Marker Levels and the Dynamic Changes in Coronary Plaque Characteristics After Statin Therapy.
Stent length and outcomes after drug-eluting stent placement: time to redefine long lesions.
Comparison of second- and first-generation drug eluting stent for percutaneous coronary chronic total occlusion intervention.
Complete versus incomplete revascularization in patients with multivessel coronary artery disease treated with drug-eluting stents.
Determinants and Prognostic Significance of Periprocedural Myocardial Injury in Patients With Successful Percutaneous Chronic Total Occlusion Interventions.
Drug-eluting balloon: early enthusiasm being tempered by growing uncertainty.
Effect of Beta Blockers and Renin-Angiotensin System Inhibitors on Survival in Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
Impact of exercise-based cardiac rehabilitation on long-term clinical outcomes in patients with left main coronary artery stenosis.
Individual Long-Term Mortality Prediction Following Either Coronary Stenting or Bypass Surgery in Patients With Multivessel and/or Unprotected Left Main Disease: An External Validation of the SYNTAX Score II Model in the 1,480 Patients of the BEST an
Left Main Coronary Artery Disease: Secular Trends in Patient Characteristics, Treatments, and Outcomes.
Outcomes After Percutaneous Coronary Intervention or Bypass Surgery in Patients With Unprotected Left Main Disease.
Plaque composition and morphologic characteristics in significant left main bifurcation disease; virtual histology intravascular ultrasound study.
Prognosis of Variant Angina Manifesting as Aborted Sudden Cardiac Death.
Similar Impact of Clopidogrel or Ticagrelor on Carotid Atherosclerotic Plaque Inflammation.
Successful Recanalization of Native Coronary Chronic Total Occlusion Is Not Associated With Improved Long-Term Survival.
Transcatheter Aortic Valve Replacement With Early- and New-Generation Devices in Bicuspid Aortic Valve Stenosis.
Clinical impact and cost-effectiveness of coronary computed tomography angiography or exercise electrocardiogram in individuals without known cardiovascular disease.
Comparison of aortic root anatomy and calcification distribution between Asian and Caucasian patients who underwent transcatheter aortic valve implantation.
Dual antiplatelet therapy for coronary artery disease.
Procedural Predictors of Angiographic Restenosis After Bifurcation Coronary Stenting (from the Choice of Optimal Strategy for Bifurcation Lesions With Normal Side Branch and Optimal Stenting Strategy for True Bifurcation Lesions Studies).
Randomized Comparisons Between Different Stenting Approaches for Bifurcation Coronary Lesions With or혻Without Side Branch Stenosis.
Randomized Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: 5-Year Outcomes of the PRECOMBAT Study.
Risk score model for the assessment of coronary artery disease in asymptomatic patients with type 2 diabetes.
Stent fracture and longitudinal compression detected on coronary CT angiography in the first- and new-generation drug-eluting stents.
Stress Myocardial Perfusion CT in Patients Suspected of Having Coronary Artery Disease: Visual and Quantitative Analysis-Validation by Using Fractional Flow Reserve.
Temporal trends in revascularization strategy and outcomes in left main coronary artery stenosis: data from the ASAN Medical Center-Left MAIN Revascularization registry.
Trends in Outcomes of Revascularization for Left Main Coronary Disease or Three-Vessel Disease With the Routine Incorporation of Fractional Flow Reserve in Real Practice.
Trial of everolimus-eluting stents or bypass surgery for coronary disease.
Two cases of immediate stent fracture after zotarolimus-eluting stent implantation.
"Full metal jacket" drug-eluting stent implantation: a reasonable therapeutic option for advanced coronary artery disease?
CD137-inducing factors from T cells and macrophages accelerate the destabilization of atherosclerotic plaques in hyperlipidemic mice.
Comparison of biolimus A9-eluting (Nobori) and everolimus-eluting (Promus Element) stents in patients with de novo native long coronary artery lesions: a randomized Long Drug-Eluting Stent V trial.
Coronary computed tomographic angiographic findings in asymptomatic patients with type 2 diabetes mellitus.
Drug-eluting stents for ST-elevation myocardial infarction: ready for prime time?
Edge dissection of calcified plaque as a possible mechanism for acute coronary syndrome.
Impact of cardiac rehabilitation on angiographic outcomes after drug-eluting stents in patients with de novo long coronary artery lesions.
Impact of in-hospital bleeding according to the Bleeding Academic Research Consortium classification on the long-term adverse outcomes in patients undergoing percutaneous coronary intervention.
Impact of participation in phase I and phase II cardiac rehabilitation on long-term survival after coronary artery bypass graft surgery.
Impact of the angiographic mechanisms underlying periprocedural myocardial infarction after drug-eluting stent implantation.
Intravascular ultrasound-derived minimal lumen area criteria for functionally significant left main coronary artery stenosis.
Meta-analysis of outcomes after intravascular ultrasound-guided versus angiography-guided drug-eluting stent implantation in 26,503 patients enrolled in three randomized trials and 14 observational studies.
Multimodality imaging of attenuated plaque using grayscale and virtual histology intravascular ultrasound and optical coherent tomography.
Readmission rate after coronary artery bypass grafting versus percutaneous coronary intervention for unprotected left main coronary artery narrowing.
Response to letter regarding article, "optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial".
Sex difference in clinical outcomes after percutaneous coronary intervention in Korean population.
Temporal patterns of drug-eluting stent failure and its relationship with clinical outcomes.
Antiatherosclerotic effects of the novel Angiotensin receptor antagonist fimasartan on plaque progression and stability in a rabbit model: a double-blind placebo-controlled trial.
Association of body mass index with major cardiovascular events and with mortality after percutaneous coronary intervention.
Comparison of Zotarolimus-Eluting stent versus Sirolimus-Eluting stent for de novo coronary artery disease in patients with diabetes mellitus from the ESSENCE-DIABETES II trial.
Comparison of dual versus triple antiplatelet therapy after drug-eluting stent according to stent length (from the pooled analysis of DECLARE trials).
Comparison of intravascular ultrasound and histological findings in culprit coronary plaques between ST-segment elevation and non-ST-segment elevation myocardial infarction.
Differential impact of cilostazol on restenosis according to implanted stent type (from a pooled analysis of three DECLARE randomized trials).
Differential prognostic effect of intravascular ultrasound use according to implanted stent length.
Differential prognostic impact of high on-treatment platelet reactivity among patients with acute coronary syndromes versus stable coronary artery disease undergoing percutaneous coronary intervention.
Expression of stanniocalcin-1 in culprit coronary plaques of patients with acute myocardial infarction or stable angina.
Frequency, causes, predictors, and clinical significance of peri-procedural myocardial infarction following percutaneous coronary intervention.
Hemodynamic impact of changes in bifurcation geometry after single-stent cross-over technique assessed by intravascular ultrasound and fractional flow reserve.
Impact of ad hoc percutaneous coronary intervention with drug-eluting stents in angina patients.
Intravascular ultrasound assessment of drug-eluting stent coverage of the coronary ostium and effect on outcomes.
Intravascular ultrasound assessment of optimal stent area to prevent in-stent restenosis after zotarolimus-, everolimus-, and sirolimus-eluting stent implantation
Intravascular ultrasound predictors for edge restenosis after newer generation drug-eluting stent implantation.
Long-term comparison of apical versus asymmetric hypertrophic cardiomyopathy.
Long-term luminal change after drug-eluting stent implantation: serial angiographic follow-up study of the ZEST randomized trial.
Macrophage heterogeneity of culprit coronary plaques in patients with acute myocardial infarction or stable angina.
OCT analysis in patients with very late stent thrombosis.
Predictors for functionally significant in-stent restenosis: an integrated analysis using coronary angiography, IVUS, and myocardial perfusion imaging.
Prevalence and clinical implications of newly revealed, asymptomatic abnormal ankle-brachial index in patients with significant coronary artery disease.
Prevalence of coronary atherosclerosis in asymptomatic healthy subjects: an intravascular ultrasound study of donor hearts.
Sex differences in the visual-functional mismatch between coronary angiography or intravascular ultrasound versus fractional flow reserve.
Trends in the outcomes of percutaneous coronary intervention with the routine incorporation of fractional flow reserve in real practice.
Vascular remodeling at both branch ostia in bifurcation disease assessed by intravascular ultrasound.
Acute and long-term angiographic outcomes of side branch stenosis after randomized treatment of zotarolimus-, sirolimus-, and paclitaxel-eluting stent for coronary artery stenosis
Association of cerebral blood flow with the development of cardiac death or urgent heart transplantation in patients with systolic heart failure.
Comparative long-term efficacy and safety of drug-eluting stent versus coronary artery bypass grafting in ostial left main coronary artery disease: Analysis of the MAIN-COMPARE Registry
Comparison of Effects of Atorvastatin (20 mg) Versus Rosuvastatin (10 mg) Therapy on Mild Coronary Atherosclerotic Plaques (from the ARTMAP Trial).
Comparison of resolute zotarolimus-eluting stents and sirolimus-eluting stents in patients with denovo long coronary artery lesions: a randomized LONG-DES IV trial.
Coronary artery disease: Risk models for revascularization-the search continues.
Differential long-term outcomes of zotarolimus-eluting stents compared with sirolimus-eluting and paclitaxel-eluting stents in diabetic and non-diabetic patients: 2-year subgroup analysis of the ZEST randomized trial.
Early percutaneous mitral commissurotomy vs.conventional management in asymptomatic moderate mitral stenosis
Everolimus-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Stenosis: The PRECOMBAT-2 (Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease) study.
Expression of ADAMTS-2, -3, -13, and -14 in culprit coronary lesions in patients with acute myocardial infarction or stable angina.
Functional assessment of jailed side branches in coronary bifurcation lesions using fractional flow reserve
Impact of ischemia-guided revascularization with myocardial perfusion imaging for patients with multivessel coronary disease.
Influence of Diabetes Mellitus on Long-Term (Five-Year) Outcomes of Drug-Eluting Stents and Coronary Artery Bypass Grafting for Multivessel Coronary Revascularization.
Innate immunity markers in culprit plaques of acute myocardial infarction or stable angina.
Intravascular ultrasound assessment of optimal stent area to prevent in-stent restenosis after zotarolimus-, everolimus- and sirolimus-eluting stent implantation.
Long-Term Outcome of Stents Versus Bypass Surgery in Diabetic and Nondiabetic Patients With Multivessel or Left Main Coronary Artery Disease: A Pooled Analysis of 5775 Individual Patient Data.
Long-term luminal change after drug-eluting stent implantation; Serial angiographic follow-up study of the zest randomized trial.
Meta-Analysis of Three Randomized Trials and Nine Observational Studies Comparing Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease
OCT Findings in Patients With Recanalization of Organized Thrombi in Coronary Arteries
Outcomes After Unrestricted Use of Everolimus-Eluting and Sirolimus-Eluting Stents in Routine Clinical Practice: A Multicenter, Prospective Cohort Study
Randomized trial of optimal treatment strategies for in-stent restenosis after drug-eluting stent implantation.
Transcatheter aortic valve implantation: early experience in Korea.
Usefulness of minimal luminal coronary area determined by intravascular ultrasound to predict functional significance in stable and unstable angina pectoris
Validation of functional state of coronary tandem lesions using computational flow dynamics.
Visual-Functional Mismatch Between Coronary Angiography and Fractional Flow Reserve
. Long-Term Comparison of Drug-Eluting Stents and Coronary-Artery Bypass Grafting for Multivessel Coronary Revascularization: 5-Year Outcomes from the ASAN-Multivessel Registry
A Randomized, Double-Blind, Multicenter Comparison Study of Triple Antiplatelet Therapy With Dual Antiplatelet Therapy to Reduce Restenosis After Drug-Eluting Stent Implantation in Long Coronary Lesions Results From the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) Trial.
A point-of-care platelet function assay and C-reactive protein for prediction of major cardiovascular events after drug-eluting stent implantation.
A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus: 4-year clinical outcomes of DES-DIABETES (drug-eluting stent in patients with DIABETES mellitus) trial.
A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus: 4-year clinical outcomes of DES-DIABETES (drug-eluting stent in patients with DIABETES mellitus) trial.
A randomized, double-blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug-eluting stent implantation in long coronary lesions: results from the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) trial
Angiographic evidence of progressive lumen narrowing over 2 years following drug-eluting stent implantation
Angiographic evidence of progressive lumen narrowing over 2years following drug-eluting stent implantation.
Changes in Left Main Bifurcation Geometry After a Single-Stent Crossover Technique An Intravascular Ultrasound Study Using Direct Imaging of Both the Left Anterior Descending and the Left Circumflex Coronary Arteries Before and After Intervention
Changes in Left Main Bifurcation Geometry After a Single-Stent Crossover Technique: An Intravascular Ultrasound Study Using Direct Imaging of Both the Left Anterior Descending and the Left Circumflex Coronary Arteries Before and After Intervention.
Comparison of ADAMTS-1, -4 and -5 expression in culprit plaques between acute myocardial infarction and stable angina
Comparison of ADAMTS-1, -4 and -5 expression in culprit plaques between acute myocardial infarction and stable angina.
Comparison of ADAMTS-1,-4 and -5 expression in culprit plaques between acute myocardial infarction and stable angina.
Comparison of Differential Expression of P2Y(12) Receptor in Culprit Coronary Plaques in Patients With Acute Myocardial Infarction Versus Stable Angina Pectoris
Comparison of Differential Expression of P2Y(12) Receptor in Culprit Coronary Plaques in Patients With Acute Myocardial Infarction Versus Stable Angina Pectoris.
Comparison of Dual Drug-Eluting Cilotax Stent and Paclitaxel-Eluting Taxus Liberte Stent in Native Coronary Artery Lesions.
Comparison of Everolimus- and Sirolimus-Eluting Stents in Patients With Long Coronary Artery Lesions(A Randomized LONG-DES-III (Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III) Trial.
Comparison of Single- Versus Two-Stent Techniques in Treatment of Unprotected Left Main Coronary Bifurcation Disease.
Comparison of Zotarolimus-Eluting Stents With Sirolimus-Eluting and Paclitaxel-Eluting Stents Intimal Hyperplasia and Vascular Changes Assessed by Volumetric Intravascular Ultrasound Analysis
Comparison of dual drug-eluting Cilotax stent and paclitaxel-eluting Taxus Liberte stent in native coronary artery lesions.
Comparison of ruptured coronary plaques in patients with unstable and stable clinical presentation.
Comparison of single- versus two-stent techniques in treatment of unprotected left main coronary bifurcation disease.
Complexity of Atherosclerotic Coronary Artery Disease and Long-Term Outcomes in Patients With Unprotected Left Main Disease Treated With Drug-Eluting Stents or Coronary Artery Bypass Grafting
Complexity of atherosclerotic coronary artery disease and long-term outcomes in patients with unprotected left main disease treated with drug-eluting stents or coronary artery bypass grafting.
Comprehensive intravascular ultrasound assessment of stent area and its impact on restenosis and adverse cardiac events in 403 patients with unprotected left main disease.
Expression of HMG-CoA reductase in human coronary atherosclerotic plaques and relationship to plaque destabilisation
Impact of angiographic complete revascularization after drug-eluting stent implantation or coronary artery bypass graft surgery for multivessel coronary artery disease.
Impact of bleeding on subsequent early and late mortality after drug-eluting stent implantation.
Impact of intravascular ultrasound-guided percutaneous coronary intervention on long-term clinical outcomes in a real world population.
Incidence, predictors, treatment, and long-term prognosis of patients with restenosis after drug-eluting stent implantation for unprotected left main coronary artery disease.
Intravascular Ultrasound-Derived Predictors for Fractional Flow Reserve in Intermediate Left Main Disease.
Long-term clinical outcomes of successful versus unsuccessful revascularization with drug-eluting stents for true chronic total occlusion.
Long-term comparison of drug-eluting stents and coronary artery bypass grafting for multivessel coronary revascularization: 5-year outcomes from the Asan Medical Center-Multivessel Revascularization Registry.
Optical Coherence Tomographic Analysis of In- Stent Neoatherosclerosis After Drug-Eluting Stent Implantation.
Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation.
Preintervention Angiographic and Intravascular Ultrasound Predictors for Side Branch Compromise After a Single-Stent Crossover Technique.
Preventive Strategies of Renal Insufficiency in Patients With Diabetes Undergoing Intervention or Arteriography (the PREVENT Trial).
Preventive strategies of renal insufficiency in patients with diabetes undergoing intervention or arteriography (the PREVENT Trial).
Randomized Trial of Stents versus Bypass Surgery for Left Main Coronary Artery Disease.
Randomized comparison of everolimus-eluting stent versus sirolimus-eluting stent implantation for de novo coronary artery disease in patients with diabetes mellitus (ESSENCE-DIABETES): results from the ESSENCE-DIABETES trial
Response to Letter Regarding Article, "Validation of Intravascular Ultrasound-Derived Parameters With Fractional Flow Reserve for Assessment of Coronary Stenosis Severity"
Validation of minimal luminal area measured by intravascular ultrasound for assessment of functionally significant coronary stenosis comparison with myocardial perfusion imaging
A Multicenter, Eight-Week Treatment, Single-Step Titration, Open-Label Study Assessing the Percentage of Korean Dyslipidemic Patients Achieving LDL Cholesterol Target with Atorvastatin Starting Doses of 10 mg, 20 mg and 40 mg.
Angiographic evidence of progressive lumen narrowing over 2years following drug-eluting stent implantation
Clinical outcomes according to coronary calcium scores in asymptomatic individuals undergoing coronary CT angiography
Comparison of Triple antiplatelet therapy and dual antiplatelet therapy in patients at high risk of restenosis after drug-eluting stent implantation (from the DECLARE-DIABETES and -LONG Trials).
Comparison of Zotarolimus-Eluting Stents With Sirolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization: The ZEST (Comparison of the Efficacy and Safety of Zotarolimus-Eluting Stent with Sirolimus-Eluting and PacliTaxel-Eluting Stent for Coronary Lesions) Randomized Trial
Comparison of zotarolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for coronary revascularization. The ZEST(Comparison of the the Efficacy and Safety of Zotarolimus-Eluting Stent with Sirolimus-Eluting and PacliTaxel-Eluting Stent.
Comparison of zotarolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for coronary revascularization: the ZEST (comparison of the efficacy and safety of zotarolimus-eluting stent with sirolimus-eluting and paclitaxel-eluting stent for coronary lesions) randomized trial.
Comparison of zotarolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for coronary revascularization: the ZEST (comparison of the efficacy and safety of zotarolimus-eluting stent with sirolimus-eluting and paclitaxel-eluting stent for coronary lesions) randomized trial.
Duration of dual antiplatelet therapy after implantation of drug-eluting stents.
Impact of the Extent of Coronary Artery Disease on Outcomes after Revascularization for Unprotected Left Main Coronary Artery Stenosis
Intravascular ultrasound findings in patients with very late stent thrombosis after either drug-eluting or bare-metal stent implantation.
Long-Term Outcomes After Stenting versus Coronary-Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease: Ten-Year Results of Bare-Metal Stents and Five-Year Results of Drug-Eluting Stents From the ASAN-MAIN Registry
Long-Term Safety and Efficacy of Stenting Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease 5-Year Results From the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) Registry.
Long-Term Safety and Efficacy of Stenting Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease: 5-Year Results From the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) Registry
Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.
Long-term outcomes of intravascular ultrasound-guided stenting in coronary bifurcation lesions.
Long-term outcomes of percutaneous mitral balloon valvuloplasty versus open cardiac surgery.
Long-term vascular changes after drug-eluting stent implantation assessed by serial volumetric intravascular ultrasound analysis.
LongTerm Outcomes After Stenting Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease(10-Year Results of Bare-Metal Stents and 5-Year Results of Drug-Eluting Stents From the ASAN–MAIN(ASAN Medical Center–Left MAIN.
Relation of plaque size to compositions as determined by an in vivo volumetric intravascular ultrasound radiofrequency analysis.
Relationship Between Multiple Plasma Biomarkers and Vulnerable Plaque Determined by Virtual Histology Intravascular Ultrasound.
Serum B-type natriuretic peptide on admission can predict the 'no-reflow' phenomenon after primary drug-eluting stent implantation for ST-segment elevation myocardial infarction.
The relationship and threshold of stent length with regard to risk of stent thrombosis after drug-eluting stent implantation.
Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation: Drug-Eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events (DECREASE registry).
Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation: Drug-eluting stenting followed by cilostazol treatment Reduces adverse serious cardiac events (DECREASE registry).
Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation:Drug-Eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events(DECREASE registry)
Validation of SYNTAX(Synergy between PCI with Taxus and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularization.
C-Reactive Protein and the Risk of Stent Thrombosis and Cardiovascular Events After Drug-Eluting Stent Implantation.
CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages.
CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages.
Comparison of higher dose and lower dose ganciclovir for cytomegalovirus prophylaxis in seropositive heart transplant recipients.
Comparison of the efficacy and safety of zotarolimus-,sirolimus-, and paclitaxel-eluting stents in patientswith ST-elevation myocardial infarction.
Impact of Diabetes Mellitus on the Treatment Effect of Percutaneous or Surgical Revascularization for Patients with Unprotected Left Main Coronary Artery Disease: A Subgroup Analysis of the MAIN-COMPARE Study
Impact of plaque characteristics analyzed by intravascular ultrasound on long-term clinical outcomes.
Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry
Prognostic influence of diabetes mellitus on long-term clinical outcomes and stent thrombosis after drug-eluting stent implantation in asian patients.
Restenosis and adverse clinical events after successful percutaneous mitral valvuloplasty: immediate post-procedural mitral valve area as an important prognosticator.
Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization Investigators. Long-term safety and effectiveness of unprotected left main coronary stenting with drug-eluting stents compared with bare-metal stents.